Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Thrombosis and Thrombolysis
Metadata
Title
Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions
Authors
Katie M. Twomley
Sunil V. Rao
Richard C. Becker
Publication date
01-04-2006
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 2/2006
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-006-5206-4

Other articles of this Issue 2/2006

Journal of Thrombosis and Thrombolysis 2/2006 Go to the issue

Case Reports and Reviews

Thrombolysis as first choice therapy in prosthetic heart valve thrombosis. A study of 68 patients

Basic Investigation and Translational Science

Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers?

Editor’s Page

Preoteomics, metabolomics and circulating endothelial progenitor cells in acute coronary syndromes

Case Reports and Reviews

Massive pulmonary embolism in a Lebanese patient doubly heterozygous for MTHFR and Factor V Leiden presenting with syncope and treated with tenecteplase

Clinical Trials

Is delayed facilitated percutaneous coronary intervention better than immediate in reperfused myocardial infarction? Six months follow up findings

Laboratory Medicine

Monitoring anticoagulation in atrial fibrillation

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits